These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 1661859

  • 1. Evaluation of the sites of opioid influence on anterior pituitary hormone secretion using a quaternary opiate antagonist.
    Simpkins JW, Swager D, Millard WJ.
    Neuroendocrinology; 1991 Oct; 54(4):384-90. PubMed ID: 1661859
    [Abstract] [Full Text] [Related]

  • 2. Effects of melatonin in vivo upon luteinizing hormone and prolactin releases induced by opiate receptor antagonists in adult male rats.
    Shacoori V, Saïag B, Lemay V, Girre A, Rault B.
    J Endocrinol Invest; 1996 Feb; 19(2):76-82. PubMed ID: 8778169
    [Abstract] [Full Text] [Related]

  • 3. Melatonin modifies prolactin release induced by opiate antagonists in male rats.
    Shacoori V, Saiag B, Rault B.
    Endocr Res; 1995 Aug; 21(3):545-53. PubMed ID: 7588425
    [Abstract] [Full Text] [Related]

  • 4. Evidence for the delivery of narcotic antagonists to the colon as their glucuronide conjugates.
    Simpkins JW, Smulkowski M, Dixon R, Tuttle R.
    J Pharmacol Exp Ther; 1988 Jan; 244(1):195-205. PubMed ID: 3335997
    [Abstract] [Full Text] [Related]

  • 5. The opioid receptor antagonist nalmefene reduces responding maintained by ethanol presentation: preclinical studies in ethanol-preferring and outbred Wistar rats.
    June HL, Grey C, Warren-Reese C, Durr LF, Ricks-Cord A, Johnson A, McCane S, Williams LS, Mason D, Cummings R, Lawrence A.
    Alcohol Clin Exp Res; 1998 Dec; 22(9):2174-85. PubMed ID: 9884166
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the duration of action of nalmefene and naloxone on the hypothalamic-pituitary axis of the rhesus monkey.
    VanVugt DA, Webb MY, Reid RL.
    Neuroendocrinology; 1989 Mar; 49(3):275-80. PubMed ID: 2716954
    [Abstract] [Full Text] [Related]

  • 7. Central opioid receptors differentially regulate the nalmefene-induced suppression of ethanol- and saccharin-reinforced behaviors in alcohol-preferring (P) rats.
    June HL, Cummings R, Eiler WJ, Foster KL, McKay PF, Seyoum R, Garcia M, McCane S, Grey C, Hawkins SE, Mason D.
    Neuropsychopharmacology; 2004 Feb; 29(2):285-99. PubMed ID: 14603266
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vivo characterization of the opioid antagonist nalmefene in mice.
    Osborn MD, Lowery JJ, Skorput AG, Giuvelis D, Bilsky EJ.
    Life Sci; 2010 Apr 10; 86(15-16):624-30. PubMed ID: 20159022
    [Abstract] [Full Text] [Related]

  • 12. The effects of chronic naloxone on pituitary hormone secretion in female rats.
    Gabriel SM, Simpkins JW, Millard WJ.
    Brain Res Bull; 1984 Apr 10; 12(4):359-62. PubMed ID: 6329481
    [Abstract] [Full Text] [Related]

  • 13. Central opioid receptors mediate glucoprivic inhibition of pituitary LH secretion.
    Briski KP.
    Am J Physiol; 1997 Apr 10; 272(4 Pt 1):E517-22. PubMed ID: 9142869
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Behavioral effects of 6-methylene naltrexone (nalmefene) in rhesus monkeys.
    France CP, Gerak LR.
    J Pharmacol Exp Ther; 1994 Sep 10; 270(3):992-9. PubMed ID: 7932212
    [Abstract] [Full Text] [Related]

  • 17. The implication of opiates in the glucocorticoid-mediated inhibition of LH secretion in rats.
    Belhadj H, de Besi L, Bardin CW, Thau RB.
    J Endocrinol; 1989 Aug 10; 122(2):451-6. PubMed ID: 2671240
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.
    Walker BM, Koob GF.
    Neuropsychopharmacology; 2008 Feb 10; 33(3):643-52. PubMed ID: 17473837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.